Los Angeles/ Retail & Industry
AI Assisted Icon
Published on May 15, 2019
Los Angeles companies are attracting new investmentPhoto: HUM Nutrition/Facebook

Los Angeles-based medical robotics company Neural Analytics has secured $22 million in Series C funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced May 8 and financed by Alpha Edison.

According to its Crunchbase profile, "Neural Analytics, Inc. is a medical robotics company developing and commercializing technologies to measure and track brain health. The company’s Lucid Robotic System (Lucid™ M1 Transcranial Doppler Ultrasound System and NeuralBot™ System) is a robotically assisted ultrasound system for brain health assessment. It combines an all-in-one neurovascular ultrasound device, designed to non-invasively measure and display brain blood flow information under the guidance of a healthcare professional."

The six-year-old company has raised 10 previous funding rounds, including a $15 million Series B round in 2018.

The round brings total funding raised by Los Angeles companies in science and engineering over the past month to $27 million, and increase of $23 million from the month before. The local science and engineering industry has produced 31 funding rounds over the past year, yielding a total of $115 million in venture funding.

In other local funding news, wellness company HUM Nutrition announced a $15 million Series B funding round on April 29, led by Sonoma Brands.

According to Crunchbase, "HUM is an LA based start-up with one mission: to make you look great and feel even greater. Hum's online platform connects consumers with Nutrition experts and cutting edge products. The company’s profiling methodology and line of vitamins have been developed with leading researchers in nutrition and are widely popular within the nutritionist community."

The company also raised a $5 million Series A round in 2017.


This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.